These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 29413273)

  • 1. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
    Nabavizadeh N; Waller JG; Fain R; Chen Y; Degnin CR; Elliott DA; Mullins BT; Patel IA; Dyer BA; Fakhoury K; Naugler WE; Farsad K; Tanyi JA; Fuss M; Thomas CR; Hung AY
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):577-585. PubMed ID: 29413273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
    Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer.
    Toesca DAS; Osmundson EC; von Eyben R; Shaffer JL; Koong AC; Chang DT
    Pract Radiat Oncol; 2017; 7(3):173-182. PubMed ID: 28343896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.
    Hardy-Abeloos C; Lazarev S; Ru M; Kim E; Fischman A; Moshier E; Rosenzweig K; Buckstein M
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):968-976. PubMed ID: 31536781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy.
    Gkika E; Bettinger D; Krafft L; Schultheiss M; Neeff HP; Maruschke L; Schulenburg M; Adebahr S; Kirste S; Nestle U; Thimme R; Grosu AL; Brunner TB
    Strahlenther Onkol; 2018 May; 194(5):403-413. PubMed ID: 29322205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Velec M; Haddad CR; Craig T; Wang L; Lindsay P; Brierley J; Brade A; Ringash J; Wong R; Kim J; Dawson LA
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):939-946. PubMed ID: 28333016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation.
    Pursley J; El Naqa I; Sanford NN; Noe B; Wo JY; Eyler CE; Hwang M; Brock KK; Yeap BY; Wolfgang JA; Hong TS; Grassberger C
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):986-995. PubMed ID: 32353390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential for Midtreatment Albumin-Bilirubin (ALBI) Score to Individualize Liver Stereotactic Body Radiation Therapy.
    Jackson WC; Hartman HE; Gharzai LA; Maurino C; Karnak DM; Mendiratta-Lala M; Parikh ND; Mayo CS; Haken RKT; Schipper MJ; Cuneo KC; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):127-134. PubMed ID: 33878421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma.
    Dreher C; Høyer KI; Fode MM; Habermehl D; Combs SE; Høyer M
    Acta Oncol; 2016 Jul; 55(7):886-91. PubMed ID: 26878669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin-bilirubin score is a useful predictor of worsening liver reserve after stereotactic body radiation therapy in elderly Japanese patients with hepatocellular carcinoma.
    Yoshino Y; Suzuki G; Shiomi H; Kimoto T; Seri S; Yamazaki H; Yamada K
    J Radiat Res; 2024 Mar; 65(2):244-250. PubMed ID: 38415344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Suresh K; Owen D; Bazzi L; Jackson W; Ten Haken RK; Cuneo K; Feng M; Lawrence TS; Schipper MJ
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):131-137. PubMed ID: 29128147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy.
    Lo CH; Liu MY; Lee MS; Yang JF; Jen YM; Lin CS; Chao HL; Shen PC; Huang WY
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):145-152. PubMed ID: 28816140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy.
    Su TS; Yang HM; Zhou Y; Huang Y; Liang P; Cheng T; Chen L; Li LQ; Liang SX
    Radiat Oncol; 2019 Mar; 14(1):50. PubMed ID: 30917853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma.
    Culleton S; Jiang H; Haddad CR; Kim J; Brierley J; Brade A; Ringash J; Dawson LA
    Radiother Oncol; 2014 Jun; 111(3):412-7. PubMed ID: 24906626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma.
    Jun BG; Kim YD; Cheon GJ; Kim ES; Jwa E; Kim SG; Kim YS; Kim BS; Jeong SW; Jang JY; Lee SH; Kim HS
    Korean J Intern Med; 2018 Nov; 33(6):1093-1102. PubMed ID: 28844122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.
    Son SH; Choi BO; Ryu MR; Kang YN; Jang JS; Bae SH; Yoon SK; Choi IB; Kang KM; Jang HS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1073-80. PubMed ID: 20207492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
    Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas.
    Yeung R; Beaton L; Rackley T; Weber B; Hamm J; Lee R; Camborde M; Pearson M; Duzenli C; Loewen SK; Liu M; Ma R; Schellenberg D
    Clin Oncol (R Coll Radiol); 2019 Jun; 31(6):365-373. PubMed ID: 30792051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities.
    Lazarev S; Hardy-Abeloos C; Factor O; Rosenzweig K; Buckstein M
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2077-2083. PubMed ID: 30088143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting.
    Gerum S; Heinz C; Belka C; Walter F; Paprottka PM; De Toni EN; Roeder F
    Strahlenther Onkol; 2020 Apr; 196(4):334-348. PubMed ID: 31732784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.